Skip to main content
SpringerLink
Log in

Concomitant 1p/19q co-deletion and IDH1/2, ATRX, and TP53 mutations within a single clone of “dual-genotype” IDH-mutant infiltrating gliomas

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Appay R, Tabouret E, Macagno N, Touat M, Carpentier C, Colin C et al (2018) IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas. Neuro Oncol 20:716–718. https://doi.org/10.1093/neuonc/noy014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498. https://doi.org/10.1056/NEJMoa1402121

    Article  CAS  PubMed  Google Scholar 

  3. Dahlback HS, Gorunova L, Brandal P, Scheie D, Helseth E, Meling TR et al (2011) Genomic aberrations in diffuse low-grade gliomas. Genes Chromosomes Cancer 50:409–420. https://doi.org/10.1002/gcc.20866

    Article  CAS  PubMed  Google Scholar 

  4. Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H et al (2015) Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372:2499–2508. https://doi.org/10.1056/NEJMoa1407279

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Huse JT, Diamond EL, Wang L, Rosenblum MK (2015) Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma: a true "oligoastrocytoma"? Acta Neuropathol 129:151–153. https://doi.org/10.1007/s00401-014-1359-y

    Article  PubMed  Google Scholar 

  6. Jenkins RB, Xiao Y, Sicotte H, Decker PA, Kollmeyer TM, Hansen HM et al (2012) A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet 44:1122–1125. https://doi.org/10.1038/ng.2388

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Leeper HE, Caron AA, Decker PA, Jenkins RB, Lachance DH, Giannini C (2015) IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas. Oncotarget 6:30295–30305. https://doi.org/10.18632/oncotarget.4497

    Article  PubMed  PubMed Central  Google Scholar 

  8. Louis DN, Giannini C, Capper D, Paulus W, Figarella-Branger D, Lopes MB et al (2018) cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol 135:639–642. https://doi.org/10.1007/s00401-018-1826-y

    Article  PubMed  Google Scholar 

  9. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization Classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1

    Article  PubMed  Google Scholar 

  10. Louis DN, Wesseling P, Paulus W, Giannini C, Batchelor TT, Cairncross JG et al (2018) cIMPACT-NOW update 1: not otherwise specified (NOS) and not elsewhere classified (NEC). Acta Neuropathol 135:481–484. https://doi.org/10.1007/s00401-018-1808-0

    Article  PubMed  Google Scholar 

  11. Qu M, Olofsson T, Sigurdardottir S, You C, Kalimo H, Nister M et al (2007) Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas. Acta Neuropathol 113:129–136. https://doi.org/10.1007/s00401-006-0142-0

    Article  CAS  PubMed  Google Scholar 

  12. Sahm F, Reuss D, Koelsche C, Capper D, Schittenhelm J, Heim S et al (2014) Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma. Acta Neuropathol 128:551–559. https://doi.org/10.1007/s00401-014-1326-7

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Cinthya J. Zepeda-Mendoza and Rachael A. Vaubel are co-first authors.

Authors and Affiliations

  1. Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

    Cinthya J. Zepeda-Mendoza, Rachael A. Vaubel, Cristiane M. Ida & Robert B. Jenkins

  2. Department of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA

    Rachael A. Vaubel, Aditya Raghunathan & Caterina Giannini

  3. Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA

    Shabnam Zarei

  4. Medical Laboratories of Marquette, Marquette, MI, USA

    Martin Matthews

  5. WellStar Health System, Kennestone Regional Medical Center, Marietta, GA, USA

    Sara Acree

Authors
  1. Cinthya J. Zepeda-Mendoza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rachael A. Vaubel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shabnam Zarei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cristiane M. Ida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Martin Matthews
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sara Acree
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Aditya Raghunathan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Caterina Giannini
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Robert B. Jenkins
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert B. Jenkins.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 6108 kb)

Supplementary file2 (XLSX 22 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zepeda-Mendoza, C.J., Vaubel, R.A., Zarei, S. et al. Concomitant 1p/19q co-deletion and IDH1/2, ATRX, and TP53 mutations within a single clone of “dual-genotype” IDH-mutant infiltrating gliomas. Acta Neuropathol 139, 1105–1107 (2020). https://doi.org/10.1007/s00401-020-02141-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-020-02141-x

Search

Navigation